Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Clinical trial NCT02769962 · TERMINATED
Trial details
- NCT number
- NCT02769962
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2023-04-19
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.